种族影响KPS≥80的胶质母细胞瘤患者生存并与维甲酸代谢基因标志物相关
研究比较非洲裔美国人与白人胶质瘤患者的临床结局和分子生物学差异,数据来自TCGA和NMEDW。TCGA中931例白人和64例非洲裔美国胶质瘤患者分析显示,KPS≥80的非洲裔美国IV级胶质母细胞瘤患者死亡风险显著低于相似白人患者(HR=0.47,95%CI 0.23-0.98,P=0.0444)。基因表达分析提示13个基因及维甲酸代谢通路可能与生存延长相关。
要点
- KPS≥80的非洲裔美国胶质母细胞瘤患者死亡风险显著低于白人(HR=0.47,95%CI 0.23-0.98,P=0.0444)。
- 13个基因可能与非洲裔患者生存延长相关,包括CRYBB2等。
- 维甲酸代谢通路在生存较长的非洲裔胶质母细胞瘤患者中显著上调(Z-score=-2.10,校正P=0.0449)。
核心结论
- 非洲裔美国人胶质瘤患者生存期延长,且仅受初始KPS评分影响。
- 既往与癌症种族差异相关的基因及维甲酸代谢相关通路可能在胶质瘤病因学中起重要作用。
- 未来探索这些基因和通路可能为该不治之症提供新疗法。
研究设计与样本
- 临床信息和分子谱(包括基因表达芯片、非 silent 体细胞突变、DNA甲基化和蛋白表达)从癌症基因组图谱(TCGA)下载。
- 电子病历从西北医学企业数据仓库(NMEDW)提取用于分析。
- 纳入II-IV级胶质瘤患者。
- 分析TCGA中931例白人和64例非洲裔美国胶质瘤患者。
主要发现
- KPS≥80的非洲裔美国IV级胶质母细胞瘤患者死亡风险显著低于相似白人患者(HR=0.47,95%CI 0.23-0.98,P=0.0444,C-index=0.68)。
- 进一步比较KPS≥80的非洲裔美国胶质母细胞瘤患者与白人的基因表达谱,外推与非洲裔患者生存增加显著相关的基因,揭示13个基因可能在该关联中起作用。
- 这13个基因包括既往在非洲裔美国乳腺癌和结肠癌患者中表达升高的基因(如CRYBB2)。
- 基因集富集分析显示,维甲酸(RA)代谢通路在生存长于白人的非洲裔美国胶质母细胞瘤患者中显著上调(Z-score=-2.10,校正P=0.0449)。
关键数值与推荐
- KPS≥80的非洲裔美国IV级胶质母细胞瘤患者 vs 相似白人患者:HR=0.47(95%CI 0.23-0.98),P=0.0444,C-index=0.68。
- 维甲酸代谢通路在生存较长的非洲裔美国胶质母细胞瘤患者中上调:Z-score=-2.10,校正P=0.0449。
- 13个基因可能与非洲裔患者生存增加相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To study whether the clinical outcome and molecular biology of gliomas in African-American patients fundamentally differ from those occurring in Whites. METHODS: The clinical information and molecular profiles (including gene expression array, non-silent somatic mutation, DNA methylation and protein expression) were downloaded from The Cancer genome atlas (TCGA). Electronic medical records were abstracted from Northwestern Medicine Enterprise Data Warehouse (NMEDW) for analysis as well. Grade II-IV Glioma patients were all included. RESULTS: 931 Whites and 64 African-American glioma patients from TCGA were analyzed. African-American with Karnofsky performance score (KPS) ≥ 80 have significantly lower risk of death than similar white Grade IV Glioblastoma (GBM) patients [HR (95% CI) = 0.47 (0.23, 0.98), P = 0.0444, C-index = 0.68]. Therefore, we further compared gene expression profiles between African-American GBM patients and Whites with KPS ≥ 80. Extrapolation of genes significantly associated with increased African-American patient survival revealed a set of 13 genes with a possible role in this association, including elevated expression of genes previously identified as increased in African-American breast and colon cancer patients (e.g. CRYBB2). Furthermore, gene set enrichment analysis revealed retinoic acid (RA) metabolism as a pathway significantly upregulated in African-American GBM patients who survive longer than Whites (Z-score = - 2.10, Adjusted P-value = 0.0449). CONCLUSIONS: African Americans have prolonged survival with glioma which is influenced only by initial KPS score. Genes previously associated with both racial disparities in cancer and pathways associated with RA metabolism may play an important role in glioma etiology. In the future exploration of these genes and pathways may inform novel therapies for this incurable disease.
引用
- Wu M, Miska J, Xiao T, et al. Race influences survival in glioblastoma patients with KPS ≥ 80 and associates with genetic markers of retinoic acid metabolism. J Neurooncol. 2019. PMID: 30706176. doi:10.1007/s11060-019-03110-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。